DOI:
10.1039/C4LC00928B
(Paper)
Lab Chip, 2015,
15, 86-93
Using a patterned grating structure to create lipid bilayer platforms insensitive to air bubbles†
Received
9th August 2014
, Accepted 24th September 2014
First published on 24th September 2014
Abstract
Supported lipid bilayers (SLBs) have been used for various biosensing applications. The bilayer structure enables embedded lipid membrane species to maintain their native orientation, and the two-dimensional fluidity is crucial for numerous biomolecular interactions to occur. The platform integrated with a microfluidic device for reagent transport and exchange has great potential to be applied with surface analytical tools. However, SLBs can easily be destroyed by air bubbles during assay reagent transport and exchange. Here, we created a patterned obstacle grating structured surface in a microfluidic channel to protect SLBs from being destroyed by air bubbles. Unlike all of the previous approaches using chemical modification or adding protection layers to strengthen lipid bilayers, the uniqueness of this approach is that it uses the patterned obstacles to physically trap water above the bilayers to prevent the air–water interface from directly coming into contact with and peeling the bilayers. We showed that our platform with certain grating geometry criteria can provide promising protection to SLBs from air bubbles. The required obstacle distance was found to decrease when we increased the air-bubble movement speed. In addition, the interaction assay results from streptavidin and biotinylated lipids in the confined SLBs suggested that receptors at the SLBs retained the interaction ability after air-bubble treatment. The results showed that the developed SLB platform can preserve both high membrane fluidity and high accessibility to the outside environment, which have never been simultaneously achieved before. Incorporating the built platforms with some surface analytical tools could open the bottleneck of building highly robust in vitro cell-membrane-related bioassays.
Introduction
Supported lipid bilayers (SLBs) have been used in various biosensing applications.1–3 The bilayer structure enables embedded membrane species to maintain their native orientation and conformation, and the two-dimensional fluidity is crucial for numerous biomolecular interactions to occur.4,5 Incorporating SLBs into cell-membrane-related bioassays, such as drug screening6,7 and toxin detection,8,9 have been considered crucial for obtaining accurate assay results and for discovering new phenomena. However, conventional SLBs easily delaminate after being exposed to air–water interfaces. In the steps of various bioassays, the samples are inevitably exposed to air during sample transport or reagent exchange, causing difficulty in obtaining robust assay results.10,11 For example, when surface plasmon resonance and quartz crystal microbalance techniques are used for detecting biomolecular interactions, multiple reagent additions and washes are required to obtain binding and equilibrium constants. Developing SLB platforms that are insensitive to the air–water interface and retain their bilayer structure and fluidity is critical for broadening the capability of developing cell-membrane-related in vitro assays.
Several approaches have been developed for preventing SLBs from delaminating after being exposed to an air–water interface. Some of these studies involved using polymerizable lipids to cross-link the lipid bilayer structure12–14 or lipopolymers—lipids with polymers attached to the head groups—to increase the rigidity and degree of membrane hydration.15 Other approaches involved modifying solid support surfaces by using a tethered cholesteryl group,16 zirconium phosphate,17,18 γ-aminopropyl saline,19–21 or negatively charged polydimethylsiloxane (PDMS)22 to provide strong interactions between the support surfaces and the lipid bilayers to overcome the interfacial peeling force. These studies have successfully developed reinforced lipid bilayers that can retain their integrity against air–water interfacial force; however, modifying the chemical structure of the lipid or strongly tethering the lipid membrane to the modified supports can alter the native environment for certain membrane species. Another category of studies involved adding biomolecules, such as proteins9,23 and disaccharides,24–29 to form protective layers above the membrane for enhancing the bending modulus of the membrane and preventing the lipid bilayer from curling during delamination. Although most of the studies in this category have developed air-stable lipid bilayers exhibiting promising stability and fluidity, the steric hindrance caused by the protective layer can block the accessibility of analytes in an aqueous solution to the target receptors located on the lipid bilayer. Overall, all of the previous approaches achieve air stability by increasing membrane rigidity and thus could influence some membrane properties crucial for the interesting biological phenomena to occur.
In this study, we developed an SLB platform with patterned obstacle gratings that can prevent the lipid membrane from directly coming into contact with the air–water interface when an air bubble is introduced during reagent exchange. Unlike all of the previous studies using chemical methods to modify the surface to create air-stable SLBs, we used a physical method inspired by previous observations that trenches or pores on a hydrophilic surface can trap some water.30,31 We expected that if lipid bilayers can be confined in the trenched regions, they could be protected by the trapped water and not directly affected by the deleterious air–water interfacial force. The gratings were patterned perpendicular to the reagent flow direction in a microchannel to achieve optimum water-retention ability between the grating obstacles. To determine the appropriate geometry criterion for the grating structure to function, we prepared a range of grating distances and examined the membrane integrity and mobility by using fluorescence microscopy and fluorescence recovery after photobleaching (FRAP) before and after air-bubble treatment. In addition, we used streptavidin–biotinylated lipid as a model system to demonstrate that not only the lipid bilayer integrity but also the receptor–ligand interaction can remain in the developed platform after air-bubble treatment.
Experimental section
Materials
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased from Avanti Polar Lipids (Alabaster, AL, USA). Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (Texas Red® DHPE), N-((6-(biotinoyl)amino) hexanoyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt (Biotin-X DHPE), and Alexa Fluor® 488-conjugated streptavidin were purchased from Life Technologies (Grand Island, NY, USA). Bovine serum albumin (BSA) was purchased from Sigma-Aldrich (St. Louis, MO, USA).
Preparation of substrates exhibiting a photoresist grating structure by using photolithography
A glass coverslip substrate exhibiting a micrometer-sized photoresist grating structure was prepared by photolithography. The bare glass was cleaned by the RCA cleaning procedure (5
:
1
:
1 H2O
:
H2O2
:
NH4OH) before performing the microfabrication process. A thin film of negative photoresist SU-8 2002 (MicroChem Corp., USA) was spin-coated on the glass substrate at 3000 rpm for 30 s to achieve the desired thickness (approximately 2 μm) and soft-baked at 90 °C for 1 min. The substrate was then placed under a chrome mask with a desired grating pattern and exposed to ultraviolet radiation at an exposure energy of 80 mJ cm−2. The substrate was then postbaked at 95 °C for 2 min and developed in an SU-8 developer (MicroChem Corp., USA) through gentle shaking for 20 s. The glass substrate with the photoresist pattern was rinsed with isopropyl alcohol and dried using nitrogen gas. The substrate was then hard-baked at 150 °C for 1 h to enhance the attachment of SU-8 to the glass.
Preparation of large unilamellar vesicles
The purchased lipids were mixed in a chloroform solution for obtaining desired compositions. The chloroform solvent was then removed using nitrogen, leaving a lipid cake at the bottom of the container. The lipid cake was then placed in a vacuum for 5 h to ensure the complete removal of residual chloroform. The lipids were then reconstituted in a HEPES buffer (10 mM HEPES and 123 mM NaCl, pH 7.4) at a concentration of 2 mg mL−1, and extruded through a 50 nm polycarbonate filter 19 times by using an Avanti Mini-Extruder (Alabaster, AL, USA) to form large unilamellar vesicles (LUVs).
Formation of supported lipid bilayers on the substrate with a photoresist grating structure inside a microfluidic device
The prepared substrate with SU-8 photoresist grating structure was cleaned using argon plasma for 10 min. The plasma can change the wetting properties and surface roughness of SU-8.32,33 A PDMS slab with a microchannel (100 μm × 500 μm × 1.5 cm) was then treated with oxygen plasma for 30 s and sealed with the glass coverslip. The LUV solution was then flowed into the microchannel, followed by a 10 min incubation for vesicle deposition to form SLBs on the area of bare glass that was not covered with the SU-8 grating. The excess lipid vesicles were then washed with water.
Dehydration and rehydration of the supported lipid bilayer by introducing an air bubble into the microchannel
An air bubble was pumped into the microchannel at a flow rate of either 3 μL min−1 (60 mm min−1) or 300 μL min−1 (6000 mm min−1) to create an air–water interface passing through the SLB platform inside the microchannel. The size of the bubble was approximately 100 μL, and it required 33 min or 3.33 min to pump the entire bubble through the channel. The beginning of the dehydration state was defined as the time immediately after the air bubble entered the microchannel. The beginning of the rehydration state was defined as the point at which the air bubble left the microchannel completely.
Fluorescence microscopy and fluorescence recovery after photobleaching
A 200 mW diode-pumped solid-state green laser module (Unice, Taiwan) at 532 nm was used for photobleaching Texas Red DHPE in a lipid bilayer sample for 0.1 s. The bleached spot can be fitted to a Gaussian profile with a half-maximum width of approximately 10 μm. The recovery time evolution images of a bleached spot was recorded using an inverted microscope (Olympus IX81, Olympus, Japan) equipped with a charge-coupled-device camera (ORCA-R2, Hamamatsu, Japan) and a 20× objective lens (UPLSAPO, Olympus). The intensity recovery data in the region of interest were fitted using MATLAB (MathWorks, Natick, MA, USA) to obtain the diffusion coefficient of the SLB. The details of the fitting algorithm are shown in our previous study.34
Streptavidin–biotinylated lipid interaction test
DOPC SLBs doped with 0.5 mol% Biotin-X DHPE were formed on a glass substrate with or without SU-8 grating obstacles in a microchannel. An air bubble was then pumped through the microchannel at a flow rate of 3 μL min−1 (60 mm min−1). Subsequently, 250 μg mL−1 BSA solution was flowed into the microchannel and incubated for 30 min to prevent the subsequent nonspecific binding of streptavidin to the region not covered with the SLBs. The excess BSA solution was then flushed away, and 10 μg mL−1 Alexa Fluor® 488-conjugated streptavidin was flowed in and incubated for 30 min for binding. Excess streptavidin in bulk was flushed later. A control experiment was conducted without introducing an air bubble into the microchannel. The amount of streptavidin binding to the biotinylated lipid in the membrane was determined by measuring the fluorescence intensity after background subtraction.
Results and discussion
Patterned photoresist grating for preventing the air–water interface from directly coming into contact with the supported lipid bilayer
To develop an air-stable SLB platform, we constructed obstacle gratings on a glass surface and deposited lipid membranes in the regions confined by the obstacles. We used a photoresist, SU-8, as our obstacle material so that we could easily use photolithography to fabricate a patterned obstacle grating structure at various sizes and geometries on glass surfaces. In addition, lipid vesicles can be deposited to form SLBs only on glass, not on SU-8 photoresist material. Therefore, we obtained pieces of SLBs confined by the photoresist obstacles. As shown in Fig. 1, when the air–water interface front moved, the SLB were preserved because the obstacle gratings trapped some water and prevented the air–water interface from directly coming into contact with the SLB on the bottom surface. Although the trapped water layer above the SLB could later evaporate from the surface, no substantial interfacial force in the peel-off direction could be directly applied to the SLB, and the bilayer structure was preserved.
 |
| Fig. 1 Patterned SU-8 grating structure on the glass surface in a microfluidic device can prevent the air–water interface from directly coming into contact with the confined SLBs. (a) The grating is set perpendicular to the air–water interface moving direction when an air bubble is introduced into the device. (b)–(d) Top view fluorescence images taken during air-bubble treatment at 25 °C. 0.5 mol% Texas Red DHPE was added into the lipid membrane to reveal the locations of SLBs (bright) and the obstacle grating (dark). The bright curved rings across the channel in (b) and (d) are the air–water interfaces. The slightly brighter regions around the dark grating below an air bubble are probably due to the meniscus light diffraction. (e)–(g) Side view illustrations inside a microchannel at the stages corresponding to (b)–(d), respectively. | |
As shown in Fig. 1(a), the obstacle grating was set perpendicular to the flow direction in a microchannel to maximize the size of each piece of the SLB confined in the obstacle grating. A large continuous piece of the lipid bilayer is usually desirable in real applications because of the fewer possible disturbances from the grating obstacles. According to the proposed mechanism, the obstacles need to orient in a way that they can truncate the interfacial moving front before the water receding tail comes into contact with the lipid bilayer. When the obstacle grating is set perpendicular to the flow direction, the traveling distance of the air–water interface between the two obstacles is the shortest, which maximizes the possible largest distance between the two obstacles that would not allow the interface to come into contact with the SLB.
Fig. 1(b)–(d) shows the top view fluorescence images when an air bubble was arriving in the SLB platform, when the platform was under the air bubble and when the air bubble was leaving the platform. The bright curved rings across the channel in (b) and (d) are the front and back of the air bubble, respectively. 0.5 mol% Texas Red DHPE was added to the lipid membrane to reveal the locations of the confined SLBs (bright) and the obstacle grating (dark). Fluorescence microscopy allows us to microscopically observe whether the SLBs were destroyed. Dark defects or scratches at the lipid membranes and bright debris in the solution should be observed if the SLBs were delaminated. The similar uniform looks before and after an air bubble suggests that the fluorescent SLB remained at the original place after air-bubble treatment. We also observed a slightly brighter region around the dark grating obstacles when the SLBs were below an air bubble. The brighter region was not observed when the SLBs were fully under water. Since SU-8 is shown to be hydrophilic after oxygen plasmon treatment32 as what we did in this work, water meniscus curving upwards at the sides of the obstacles could form. The brighter region is probably from the meniscus light diffraction.
Examining the integrity of confined SLBs in the obstacle grating with various obstacle distances before air-bubble treatment, under an air bubble, and after rehydration
We formed SLBs (DOPC doped with 0.5 mol% Texas Red DHPE) in the region confined in the obstacle gratings at various distances between the two neighboring obstacles, ranging from 20 μm to 200 μm, as shown in Fig. 2(a). After an air bubble was pumped into the channel with the air–water interface moving at a speed of 60 mm min−1 (3 μL min−1) (Fig. 2(b)), the SLBs confined in the grating at a distance of more than 100 μm were partially destroyed, whereas nearly all of the SLBs confined in the grating at a distance of less than 100 μm remained intact. After the air bubble left the channel and the samples were rehydrated (Fig. 2(c)), the SLBs that were intact under an air bubble remained intact. The defects in the destroyed SLBs became unclear but still appeared scratched after rehydration. The low measured diffusivity in the SLBs exhibiting dark defects suggested that those SLBs were partially peeled off or destroyed. As illustrated in Fig. 2(d), we hypothesized that the obstacle geometry criteria for the confined SLBs to remain intact are related to the water receding angle. The illustration at the left shows that the delamination can easily occur when there is no obstacle. The middle illustration shows that if the distance between the two obstacles to the height of the obstacle (w/h) is much larger than the receding angle (θ), the water receding tail would still be able to come into contact with and peel off the bilayers. The illustration at the right shows that only when the ratio is smaller than the angle could the obstacles truncate the interface before the water receding tail has a chance to come into contact with the bilayers.
 |
| Fig. 2 Fluorescence images of the SLBs composed of DOPC with 0.5 mol% Texas Red DHPE: (a) before air-bubble treatment, (b) when an air bubble was in the channel above the samples, and (c) after rehydration. The columns in the rows from left to right illustrate the conventional unconfined SLBs and those confined in the 200 μm, 100 μm, 40 μm, and 20 μm obstacle gratings. The dark defects generated after air-bubble treatment indicated the peel-off regions of the SLBs. The air–water interfacial speed was 60 mm min−1 and the system temperature was 25 °C. All of the grating obstacles exhibited a height of 2 μm and a width of 10 μm. (d) Illustrations of how the patterned obstacle geometry could determine whether the air–water interface would have a chance to peel off the SLB. From left to right: the peel-off situation easily occurs in the unconfined SLB; the peel-off situation could occur when the ratio of the distance between the two neighboring obstacles (w) to the obstacle height (h) is much larger than the water-receding contact angle (θ); some water can be retained between the obstacles above the bilayer if the ratio is smaller than θ. | |
Percentages of the unaffected supported lipid bilayers confined in gratings at various obstacle distances after air-bubble treatment
To fulfil the geometry criteria of the obstacle grating structure, we quantified the protection ability of the grating structure at various obstacle distances by performing statistical analyses on the fraction of SLBs confined in the obstacles that remained intact after an air bubble passed through. Table 1 shows the statistical results of the intact fraction of SLBs in the grating structure at obstacle distances (or confinement distances) ranging from 500 μm to 20 μm. The obstacle height was set to 2 μm since fabricating the uniform photoresist layer of a few micrometers thickness is common and easy. In addition, the 2 μm thickness is relatively thin compared to the 100 μm channel height, so that it would not significantly influence the flow pattern or the mass transfer of the species in the bulk solution to the confined SLBs. When the interfacial speed was set to 60 mm min−1, the intact fraction decreased as the confinement distance increased. When the distance was less than or equal to 40 μm, all of the lipid bilayers confined in the photoresist gratings were unaffected after an air bubble was introduced, and no visible defects could be observed after rehydration. The SLBs at the confinement distances of 100 μm still showed an unaffected fraction close to 100%. However, when the confinement distance was equal to or greater than 200 μm, the unaffected fraction decreased to less than 20%
Table 1 Comparison of the unaffected fractions of the SLBs confined in various obstacle distances when the air–water interfacial speeds in the microchannels were 60 mm min−1 and 6000 mm min−1 at 25 °C. n is the number of the experimented confined pieces of SLBs. The obstacle height is 2 μm
Confinement distance (μm) |
Unaffected fraction (60 mm min−1) |
Unaffected fraction (6000 mm min−1) |
500 |
0.0% (n = 20) |
0.0% (n = 18) |
400 |
5.3% (n = 19) |
5.3% (n = 19) |
300 |
11.1% (n = 18) |
5.9% (n = 17) |
200 |
18.5% (n = 27) |
18.2% (n = 33) |
100 |
96.2% (n = 26) |
57.1% (n = 28) |
40 |
100.0% (n = 79) |
97.1% (n = 70) |
20 |
100.0% (n = 136) |
100.0% (n = 96) |
10 |
100.0% (n = 260) |
100.0% (n = 144) |
4 |
100.0% (n = 698) |
100.0% (n = 208) |
Subsequently, we examined whether the movement speed of the air–water interface could influence the obstacle geometry criteria since the movement speed could influence the water-receding angle. The practical reagent flow rate in bioassays is in the range of a few microliters per minute to hundreds of microliters per minute.35–37 To evaluate the platform performance under these practical conditions, we applied two flow rates, 60 mm min−1 and 6000 mm min−1, which were at the low end and high end of the practical range, respectively. When the interfacial speed increased 100-fold, we observed that the confinement distance limit decreased from 100 μm to 40 μm. The unaffected fractions of the confinement distances above the limit in the systems with a 6000 mm min−1 interfacial speed were less than those in the systems with a 60 mm min−1 interfacial speed. The result showed that the grating geometry criteria were indeed related to the interfacial speed and that our platform with a confinement less than 40 μm protected the SLBs from air bubbles in the typical operating speed range for biosensing applications.
Fluorescence recovery after photobleaching for measuring membrane fluidity before air-bubble treatment, under an air bubble, and after rehydration
Fig. 3 shows a comparison of FRAP-measured diffusivities of the intact SLBs (DOPC doped with 0.5 mol% Texas Red DHPE) confined in the obstacle grating structure before and after air-bubble treatment. The diffusivities of the intact SLBs were measured for all of the unaffected SLBs confined in the obstacle gratings after air-bubble treatment. The results showed that the SLBs confined in the obstacle gratings exhibited similar diffusivities before air-bubble treatment and after rehydration, which was 1.66 ± 0.07 μm2 s−1 and 1.61 ± 0.47 μm2 s−1, respectively. The similar diffusivities suggested that the membrane retained its original integrity after air-bubble treatment. In contrast, the diffusivity of the unconfined SLBs decreased substantially after air-bubble treatment. The diffusivity was 1.77 ± 0.07 μm2 s−1 before air-bubble treatment but 0.82 ± 0.63 μm2 s−1 after rehydration, indicating that some defects might have been introduced. The high standard deviation indicated the poor quality of the membrane. In addition, no fluorescence recovery was observed in the unconfined SLBs under an air bubble, but the diffusivity of the confined SLBs remained measurable (1.49 ± 0.06 μm2 s−1) and similar to the diffusivity when they were measured under water. Because water is required for the lateral fluidity of lipid bilayers, this observation suggested water retention above the SLB between the obstacles after an air–water interface passed through. The diffusivities under an air bubble were measured in 5 min after the air bubble was introduced to the platform. We found that if the diffusivities were measured after 30 min, the trapped water would likely evaporate completely, and the diffusivity of the confined SLBs was close to zero. The comparable diffusivity of the confined SLBs before air-bubble treatment, under an air bubble, and after rehydration suggested the promising preservation of lipid bilayers after being exposed to an air–water interface.
 |
| Fig. 3 Comparisons of the diffusivities of the confined and unconfined SLBs before air-bubble treatment, under an air bubble, and after rehydration. The SLBs were composed of DOPC doped with 0.5 mol% Texas Red DHPE. The yellow bar represents the diffusivities of SLBs confined in the 100 μm obstacle grating structure exhibiting a height of 2 μm, and the blue bar represents the diffusivities of the unconfined SLBs. No fluorescence recovery was observed in the unconfined SLBs under an air bubble, and thus, the diffusivity was not measurable. The air–water interfacial speed was 60 mm min−1 and the system temperature was 25 °C. | |
Streptavidin–biotinylated lipid interactions remained in the developed platform after air-bubble treatment
In this study, we used biotin–streptavidin as a model system to examine whether the receptor–ligand interactions in the confined SLBs remained after air-bubble treatment. We incorporated 0.5 mol% biotinylated lipid in our SLBs as a model receptor and used fluorescence-labeled streptavidin as a model ligand. After the assay procedure was performed and the unbound ligand was removed, as discussed in the Experimental section, the measured fluorescence intensity from the platform was expected to be proportional to the amount of streptavidin bound to the biotinylated lipid. We used the same batch of fluorescence-labeled streptavidin for all of the experiments and controls to eliminate the fluorescence variation among batches, and the fluorescence dye concentration was less than the quenching limit.
We used the fluorescence intensity for comparing the biotinylated lipid–streptavidin interaction ability of the typical unconfined SLB and confined SLB with or without air-bubble treatment. Fig. 4 shows the normalized intensity of the fluorescence-labeled streptavidin bound to the SLBs under various conditions. We used the average fluorescence intensity of bound streptavidin on a typical unconfined unaffected SLB platform as the standard, and all of the other intensities were normalized to it. The left bars represent the SLBs confined in the grating, and the right bars represent the unconfined SLBs with or without air-bubble treatment.
 |
| Fig. 4 Comparison of the normalized intensity of Alexa Fluor® 488-conjugated streptavidin bound to biotin-X DHPE incorporated into the confined and typical unconfined SLBs. The red bar represents the samples that were treated with air bubbles before incubation of fluorescence-labeled streptavidin with the SLBs containing biotinylated lipids. The blue bar represents the control samples without air-bubble treatment. The grating width used in this set of experiments was 100 μm, and the air–water interfacial speed was 60 mm min−1. The system temperature was 25 °C. All of the fluorescence intensity data were normalized to the average fluorescence intensity of the typical unconfined SLB samples without air-bubble treatment. | |
The comparable normalized intensities of bound streptavidin on the confined SLB with and without air-bubble treatment suggested that biotin in the SLB retained its orientation even after an air bubble passed through the sample. In contrast, the normalized intensity of the unconfined SLB treated with an air bubble was nearly 50% of that without air-bubble treatment. The large standard deviation indicated the poor platform quality. In addition, the fluorescence images of bound streptavidin showed that the unconfined SLB with air-bubble treatment exhibited numerous defects, whereas the confined SLB appeared homogeneous. These results suggested that the bilayer integrity and receptor–ligand interaction ability remained in our platforms after air bubbles passed through.
Fluidity and outside environment accessibility compared with previously developed air-stable methods
The results of this study showed that addition of grating at a suitable obstacle distance enabled the lipid bilayer platform to retain two crucial properties, membrane fluidity and the outside environment accessibility, after air-bubble treatment. The diffusivities of the confined SLB after air-bubble treatment was 97% of its original diffusivity. In addition, the streptavidin–biotinylated lipid interaction remained mostly unchanged after air-bubble treatment.
To the best of our knowledge, none of the previous air-stable methods have been able to maintain both the high fluidity and the high outside environment accessibility of SLB platforms after air-bubble treatment. We mentioned in the Introduction section that previous methods to construct air-stable lipid membranes can be categorized into two groups. One group comprises cross-linked lipids or bound lipids for modifying solid support surfaces to increase the rigidity of lipid membranes; however, the lateral membrane mobility can be substantially reduced. For example, a zirconium-phosphate-modified surface would reduce the diffusivity of a typical SLB on it to 18% of its diffusivity before the modification.18 The diffusivity of lipid bilayers on a surface with γ-aminopropyl saline modification decreased to approximately 50% of its diffusivity before the modification.21 Positively charged lipid bilayers have a strong electrostatic interaction with a negatively charged PDMS surface; however, the interaction also affected the diffusivity and reduced the diffusivity to 49% of the SLB diffusivity on a typical glass surface.22 The second group involves using biomolecules, such as trehalose,24–29 α-α-galacto-trehalose,24 and streptavidin,23 to cover the surface of SLBs for protecting lipid bilayers from delamination. Although most of the methods in the second category retain high diffusivities, the biomolecules covering the SLBs can block the interactions of the ligand in the bulk solutions and receptors in the SLBs. All of these comparisons suggested that the proposed method can effectively preserve the two crucial properties of SLB platforms for biosensing applications and is markedly improved compared with previously developed air-stable methods.
Conclusions
In this study, we used a patterned obstacle grating structure for protecting supported lipid bilayers (SLBs) in a microfluidic device from being destroyed by air bubbles during reagent exchange and transport. The possible protection mechanism is that the grating obstacles can trap some water above the lipid bilayers to prevent the air–water interface from directly coming into contact with and peeling the lipid bilayers. The gratings were patterned perpendicular to the reagent flow direction in a microchannel to achieve optimum water-retention ability between the grating obstacles. We observed that the grating structure geometry criterion was associated with the air–water interface movement speed. The required confinement distance was shorter when the interfacial speed was faster, likely because the speed is related to the water-receding angle. We showed that, at a confinement distance less than 40 μm, our platform with a grating height equal to 2 μm can provide promising protection to SLBs from air bubbles at the typical biosensing operating speed range (60 mm min−1 to 6000 mm min−1). The FRAP measurement for the unaffected confined SLBs showed that fluidity remained nearly the same as the original fluidity after air-bubble treatment. In addition, streptavidin–biotinylated lipid interactions measured from the fluorescence intensity showed that the receptor–ligand interaction ability remained similar after air-bubble treatment. Compared with other previously air-stable methods, the method developed here more effectively retains membrane fluidity and the accessibility of its component to the outside environment. The physically confined SLB platform integrated with a microfluidic device for reagent transport and exchange has great potential to be applied with surface analytical tools to create highly robust in vitro cell-membrane-related bioassays in the future.
Acknowledgements
We thank National Taiwan University and the National Science Council in Taiwan for funding this work (NSC102-2221-E-002-153-MY3).
References
- M. Bally, K. Bailey, K. Sugihara, D. Grieshaber, J. Voros and B. Stadler, Small, 2010, 6, 2481–2497 CrossRef CAS PubMed.
- E. Sackmann, Science, 1996, 271, 43–48 CAS.
- M. Rough, MRS Bull., 2006, 31, 537 Search PubMed.
- J. T. Groves and M. L. Dustin, J. Immunol. Methods, 2003, 278, 19–32 CrossRef CAS.
- J. T. Groves and S. G. Boxer, Acc. Chem. Res., 2002, 35, 149–157 CrossRef CAS PubMed.
- C. Bieri, O. P. Ernst, S. Heyse, K. P. Hofmann and H. Vogel, Nat. Biotechnol., 1999, 17, 1105–1108 CrossRef CAS PubMed.
- V. Yamazaki, O. Sirenko, R. J. Schafer, L. Nguyen, T. Gutsmann, L. Brade and J. T. Groves, BMC Biotechnol., 2005, 5, 18 CrossRef PubMed.
- K. S. Phillips and Q. Cheng, Anal. Chem., 2005, 77, 327–334 CrossRef CAS PubMed.
- Y. Dong, K. S. Phillips and Q. Cheng, Lab Chip, 2006, 6, 675–681 RSC.
- P. S. Cremer and S. G. Boxer, J. Phys. Chem. B, 1999, 103, 2554–2559 CrossRef CAS.
- J. T. Groves, N. Ulman, P. S. Cremer and S. G. Boxer, Langmuir, 1998, 14, 3347–3350 CrossRef CAS.
- E. E. Ross, B. Bondurant, T. Spratt, J. C. Conboy, D. F. O'Brien and S. S. Saavedra, Langmuir, 2001, 17, 2305–2307 CrossRef CAS.
- M. Halter, Y. Nogata, O. Dannenberger, T. Sasaki and V. Vogel, Langmuir, 2004, 20, 2416–2423 CrossRef CAS.
- J. C. Conboy, S. Liu, D. F. O'Brie and S. S. Saavedra, Biomacromolecules, 2003, 4, 841–849 CrossRef CAS PubMed.
- F. Albertorio, A. J. Diaz, T. Yang, V. A. Chapa, S. Kataoka, E. T. Castellana and P. S. Cremer, Langmuir, 2005, 21, 7476–7482 CrossRef CAS PubMed.
- Y. Deng, Y. Wang, B. Holtz, J. Li, N. Traaseth, G. Veglia, B. J. Stottrup, R. Elde, D. Pei, A. Guo and X. Y. Zhu, J. Am. Chem. Soc., 2008, 130, 6267–6271 CrossRef CAS PubMed.
- B. P. Oberts and G. J. Blanchard, Langmuir, 2009, 25, 2962–2970 CrossRef CAS PubMed.
- R. M. Fabre and D. R. Talham, Langmuir, 2009, 25, 12644–12652 CrossRef CAS PubMed.
- Y. Fang, Chem. Phys. Lett., 2011, 512, 258–262 CrossRef CAS PubMed.
- Y. Fang, J. Am. Chem. Soc., 2006, 128, 3158–3159 CrossRef CAS PubMed.
- Y. Fang, A. G. Frutos and J. Lahiri, J. Am. Chem. Soc., 2002, 124, 2394–2395 CrossRef CAS PubMed.
- K. S. Phillips, Y. Dong, D. Carter and Q. Cheng, Anal. Chem., 2005, 77, 2960–2965 CrossRef CAS PubMed.
- M. A. Holden, S.-Y. Jung, T. Yang, E. T. Castellana and P. S. Cremer, J. Am. Chem. Soc., 2004, 126, 6512–6513 CrossRef CAS PubMed.
- F. Albertorio, V. A. Chapa, X. Chen, A. J. Diaz and P. S. Cremer, J. Am. Chem. Soc., 2007, 129, 10567–10574 CrossRef CAS PubMed.
- C. W. Harland, Z. Botyanszki, D. Rabuka, C. R. Bertozzi and R. Parthasarathy, Langmuir, 2009, 25, 5193–5198 CrossRef CAS PubMed.
- S. V. Bennun, R. Faller and M. L. Longo, Langmuir, 2008, 24, 10371–10381 CrossRef CAS PubMed.
- J. V. Ricker, N. M. Tsvetkova, W. F. Wolkers, C. Leidy, F. Tablin, M. Longo and J. H. Crowe, Biophys. J., 2003, 84, 3045–3051 CrossRef CAS.
- S. Chiantia, N. Kahya and P. Schwille, Langmuir, 2005, 21, 6317–6323 CrossRef CAS PubMed.
- A. E. Oliver, E. L. Kendall, M. C. Howland, B. Sanii, A. P. Shreve and A. N. Parikh, Lab Chip, 2008, 8, 892–897 RSC.
- J. Bico, U. Thiele and D. Quéré, Colloids Surf., A, 2002, 206, 41–46 CrossRef CAS.
- R. J. Jackman, D. C. Duffy, E. Ostuni, N. D. Willmore and G. M. Whitesides, Anal. Chem., 1998, 70, 2280–2287 CrossRef CAS PubMed.
- F. Walther, P. Davydovskaya, S. Zürcher, M. Kaiser, H. Herberg, A. M. Gigler and R. W. Stark, J. Micromech. Microeng., 2007, 17, 524 CrossRef CAS.
- J. Zhang, W. Zhou, M. B. Chan-Park and S. R. Conner, J. Electrochem. Soc., 2005, 152, C716–C721 CrossRef CAS PubMed.
- C.-T. Han and L. Chao, ACS Appl. Mater. Interfaces, 2014, 6, 6378–6383 CAS.
- L. G. Fägerstam, Å. Frostell-Karlsson, R. Karlsson, B. Persson and I. Rönnberg, J. Chromatogr. A, 1992, 597, 397–410 CrossRef.
- K. E. Komolov, I. I. Senin, P. P. Philippov and K.-W. Koch, Anal. Chem., 2006, 78, 1228–1234 CrossRef CAS PubMed.
- J. Lahiri, L. Isaacs, J. Tien and G. M. Whitesides, Anal. Chem., 1999, 71, 777–790 CrossRef CAS.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c4lc00928b |
|
This journal is © The Royal Society of Chemistry 2015 |
Click here to see how this site uses Cookies. View our privacy policy here.